||Relationships Between the Pharmaceutical Industry and Internal Medicine Residents
||Sec 11 - 02
|Target Review Date:
Appropriate, transparent interactions between residents and industry have the potential to benefit patients through improved physician knowledge and skill. However, excessive and/or inappropriate interactions between residents and industry may lead to inappropriate clinical care.
Guidelines are needed to ensure that processes to ensure that these interactions do not violate the fundamental ethical principles underlying medical practice. In particular, the fiduciary relationship between physicians and their patients must not be compromised by gain accruing to physicians through their involvement with Industry. A statement of principles to guide physicians’ dealings with Industry has been provided in a Canadian Medical Association (CMA) policy document. In addition, the Department of Internal Medicine has a policy governing relationships between the Pharmaceutical Industry and Physicians.
Residents are in a unique situation, and guidelines for their interaction with industry are needed. Defining these processes and procedures is the purpose of this document.
Industry Relations with Department of Internal Medicine Resident Trainees
- General Policies
- Interactions between residents and Industry must comply with the CMA guidelines, and guidelines from the College of Physicians and Surgeons of Manitoba (CPSM).
- Residents/fellows should not interact with drug representatives during working hours. Any other interactions must be within CMA and CPSM guidelines.
- Funds for research activities should comply with policies of the Department of Internal Medicine.
- Funds for Resident educational events or educational materials must be solicited and administered by the relevant residency Program Director as an unrestricted educational grant from industry.
- Negotiations and correspondence directly between residents and industry representatives is not acceptable.
- Educational grants should be administered through the appropriate education fund of each section.
- The agenda/program of educational events will be determined exclusively by the physician organizers of the event.
- Industry support for an educational event will be publicly acknowledged at the event. Representatives of sponsoring companies are welcome to attend when such attendance would be appropriate, however, product detailing at the event is not acceptable.
- Residents may attend educational conferences or meetings that are funded by Industry, as long as the following criteria are met:
- Approval of the event, and selection of the resident(s) who will attend, is made by the appropriate Program Director.
- Subsidies (money, plane ticket, hotel, etc.) for attendance at the event must be administered by a non-Industry professional body (e.g. Medical society, professional body, university, government, etc.).
- Funding from Industry to a resident (e.g. plane ticket, hotel, etc.) that is directly paid for by Industry for attendance at an educational event is not allowed.
- Meals paid for by Industry, which do not accompany an educational event are not allowed.
- Residents may not accept direct or indirect (e.g. through a sponsoring society) funding for social events such as theatre, concerts, sporting event etc.
- A letter must be forwarded to the chairperson of the Postgraduate Medical Education Committee, from a representative of the non-Industry professional body which is administering subsidies for the educational conference/meeting, indicating that the meeting is in compliance with the guidelines outlined in this document.
- The educational event must adhere to points #22 to #32 of the CMA guidelines CMA Policy: Guidelines for Physicians in Interactions with Industry (Revised 2007).
- Note that this Department of Internal Medicine policy describes criteria that must be used in the interpretation of point #32 of the CMA guidelines.
- Industry Sponsorship of Fellowship and Faculty Positions
- Industry support of Fellowship training positions within the Department, or of Faculty Professorships, is encouraged. Such support must be in the form of an unrestricted grant administered by the Department, and must not be tied to any particular individual Department member or any expectation of service or obligation of the funded physician to the funding company.
- CMA Policy: CMA Policy: Guidelines for Physicians in Interactions with Industry (Revised 2007)
- Canada’s Research Based Pharmaceutical Companies (Also known as Innovative Medicine Canada) Code of Ethical Practices (Revised 2016)
- Guidelines for Continuing Medical Education Events, External Support of Educational Programs and Working Relationships with Commercial Companies. Department of Continuing Medical Education, Faculty of Medicine, University of Manitoba, April 1997.
Is the new policy such that it still makes sense to reference form here, i.e. is it consistent? User:Ttenbergen 09:11, 8 May 2018 (CDT)
- Coyle SL. Physician-Industry Relations. Parts I and II. Position paper of the Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Annals of Int Med 133: pp396-406, 2001.
- Protecting Subjects, Preserving Trust, Promoting Progress – Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research Task Force on Financial Conflicts of Interest in Clinical Research, Association of American Medical Colleges, December 2001.
- HSC Corporate Policy & Procedure Manual. Section 20.
Cannot find policy Finance No. 20.40.10, Specific Purpose Accounts. --Tfraser1 (talk) 12:52, 30 May 2017 (CDT)
- St. Boniface Hospital Administered Funds Handbook.
Cannot find policy on internet/intranet --Tfraser1 (talk) 12:52, 30 May 2017 (CDT)
Please also refer to relevant Industry Relationships Policies.